Join
Live feed
·
INSIDERFilingvia Quantisnow
Bolt Biotherapeutics Inc. logo

SEC Form 4: Novo Holdings A/S sold $1,600,000 worth of shares (800,000 units at $2.00), decreasing direct ownership by 18% to 3,703,991 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BOLT (Bolt Biotherapeutics Inc.) and more on Quantisnow.

SEC Form 4: Novo Holdings A/S sold $1,600,000 worth of shares (800,000 units at $2.00), decreasing direct ownership by 18% to 3,703,991 units | Quantisnow